Women who have recently had an abortion, those reporting difficulty returning to a family planning provider, and current depot medroxyprogesterone acetate (DMPA) users showed substantial interest in self-administration of subcutaneous depot medroxyprogesterone acetate (DMPA-SC), according to a recent study. Survey data on contraceptive attitudes from 1,592 women in the US collected from March to July 2011 revealed:
• 21% of women reported interest in self-administration.
• Women currently using DMPA (aOR, 3.93) and women who previously used DMPA (aOR, 1.71) were more likely to have an interest in DMPA-SC compared to those who never used it.
• Women who reported having difficulty obtaining or filling a prescription were nearly twice as likely to have interest in DMPA-SC as women who reported no difficulty.
• Women surveyed at abortion sites were more likely to report interest in self-administration vs women surveyed at family planning sites.
• A desire to eliminate unnecessary return visits to a facility for repeat injections was the primary reason for interest in DMPA-SC.
Citation: Upadhyay UD, Zidar VM, Foster DG. Interest in self-administration of subcutaneous depot medroxyprogesterone acetate in the United States. [Published online ahead of print June 17, 2016]. Contraception. doi:10.1016/j.contraception.2016.06.006.
This Week's Must Reads
Must Reads in Contraception
Bleeding and Spotting with the LNG 13.5 mg IUS, Contraception; ePub 2019 Mar 1; Shimoni, et al
Contraception and Chronic Opioid Prescriptions, Contraception; ePub 2019 Feb 11; Ray-Griffith, et al
Hormonal Contraception & Coexisting Medical Conditions, Obstet Gynecol; ePub 2019 Feb; Allen, et al
Contraceptive Switching & Discontinuation, Am J Obstet Gynecol; ePub 2018 Dec 18; Simmons, et al
Efficacy of a Levonorgestrel 52-mg IU System, Obstet Gynecol; ePub 2018 Dec 4; Teal, et al